Geert W Schmid-Schonbein

Title: Geert W Schmid-Schonbein: Innovator in Medical Treatments

Introduction

Geert W Schmid-Schonbein is a prominent inventor based in Del Mar, CA (US). He has made significant contributions to the field of medical treatments, particularly in the area of protease inhibitors. With a total of 9 patents to his name, Schmid-Schonbein's work has the potential to impact the treatment of shock and multi-organ failure.

Latest Patents

One of Schmid-Schonbein's latest patents focuses on the administration of serine protease inhibitors to the stomach. The inventors have unexpectedly discovered that shock and/or potential multi-organ failure due to shock can be effectively treated by administering liquid high-dose protease inhibitor formulations to a location upstream of where pancreatic proteases are introduced into the gastrointestinal tract. Most preferably, administration is directly to the stomach, for example, via nasogastric tube under a protocol effective to treat shock by such administration without the need of providing significant quantities of the protease inhibitor to the jejunum and/or ileum.

Career Highlights

Throughout his career, Schmid-Schonbein has worked with notable institutions, including the University of California and Inflammagen, LLC. His innovative research has led to advancements in medical treatments that address critical health issues.

Collaborations

Some of his notable coworkers include Frank A DeLano and Yung-Tsai (Andrew) Lee. Their collaborative efforts have contributed to the development of groundbreaking medical solutions.

Conclusion

Geert W Schmid-Schonbein's work in the field of protease inhibitors showcases his dedication to improving medical treatments. His innovative patents and collaborations highlight his significant impact on healthcare advancements.